Current concepts in gastrointestinal photodynamic therapy

Annals of Surgery

Volumn 230, Issue 1, 1999, Pages 12-23

  Webber, John ^a   Herman, Mark ^a   Kessel, David ^a   Fromm, David ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT;

BARRETT ESOPHAGUS; CANCER PALLIATIVE THERAPY; COLORECTAL CANCER; GASTROINTESTINAL TUMOR; HEPATOBILIARY DISEASE; HUMAN; PANCREAS CANCER; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PHOTOSENSITIZATION; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; TUMOR DIAGNOSIS;

GASTROINTESTINAL NEOPLASMS; HUMANS; PHOTOCHEMOTHERAPY;

EID: 0033513036     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199907000-00003     Document Type: Review

References (135)

1. Raab O. Uber die wirkung fluoreszierender stoffe auf infusoria. Zeitschrift fur Biologie 1900; 39:524-546.
2. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 1997; 65:235-251.
3. Webber J, Kessel D, Fromm D. Photodynamic therapy using endogenous photosensitization for gastrointestinal tumors. Yale J Biol Med 1997; 70:127-137.
4. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol Biol 1992; 14:275-292.
5. Warloe T, Peng Q, Heyerdahl H, Moan J, Steen HB, Giercksky K-E. Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. In: Cortese DA (ed). 5th International Photodynamic Association Biennial Meeting, vol. 2371. Bellingham, WA: Proc SPIE; 1995:226-235.
6. McCaughan JS, Ellison EC, Guy JT, et al. Photodynamic therapy for esophageal malignancy: a prospective twelve-year study. Ann Thorac Surg 1996; 62:1005-1010.
7. Barr H, Shepherd NA, Dix A, Roberts DJH, Tan WC, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996; 348:584-585.
8. Sindelar WF, DeLaney TF, Tochner Z, et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Arch Surg 1991; 126:318-324.
9. DeLaney TF, Sindelar WF, Tochner Z, et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiation Oncology Biol Phys 1993; 25:445-457.
10. Schumacker BP, Hetzel FW. Clinical laser photodynamic therapy in the treatment of bladder carcinoma. Photochem Photobiol 1987; 46:899-901.
11. Murphree AL, Cote M, Gomer CJ. The evolution of photodynamic therapy techniques in the treatment of intraocular tumors. Photochem Photobiol 1987; 46:937-943.
12. Cortese DA, Kinsey JH. Endoscopic management of lung cancer with hematoporphyrin derivative phototherapy. Mayo Clin Proc 1982; 57:543-547.
13. Kostron H, Weiser G, Fritsch E, Grunert V. Photodynamic therapy of malignant brain tumors: clinical and neuropathological results. Photochem Photobiol 1987; 46:937-943.
14. Webber J, Kessel D, Fromm D. Photodynamic therapy using endogenous photosensitization for gastrointestinal tumors. Yale J Biol Med 1997; 70:127-137.
15. Webber J, Kessel D, Fromm D. Side effects and photosensitization of human tissues after aminolevulinic acid. J Surg Res 1997; 68:31-37.
16. Webber J, Kessel D, Fromm D. On-line fluorescence of human tissues after oral administration of 5-aminolevulinic acid. J Photochem Photobiol Biol 1997; 38:209-214.
17. Profio AE, Doiron DR, Balchum OJ, Huth GC. Fluorescence bronchoscopy for localization of carcinoma in situ. Med Phys 1983; 10:35-39.
18. Dougherty TJ, Grindey GB, Fiel R, Weishaupt KR, Boyle DG. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J NCI 1975; 55:115-21.
19. Dougherty TJ. Studies on the structure of porphyrins contained in Photofrin II. Photochem Photobiol 1987; 46:569-573.
20. 4. Cancer Res 1987; 47:4642-4645.
21. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev 1995; 24:19-33.
22. Manyak MJ, Smith PD, Harrington FS, Steinberg SM, Glatstein E, Russo A. Protection against dihematoporphyrin ether photosensitivity. Photochem Photobiol 1988; 47:823-830.
23. Doiron DR, Svaasand LO, Profio AE. Light dosimetry in tissue: application to photoradiation therapy. In: Kessel D, Dougherty TJ (eds). Advances in experimental medicine and biology. New York: Plenum Press; 1983:63-77.
24. Profio AE, Doiron DR. Dosimetry considerations in phototherapy. Medical Physics 1981; 8:190-196.
25. Malik Z, Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer 1987; 56:589-595.
26. Malik Z, Ehrenberg B, Faraggi A. Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins. J Photochem Photobiol 1989; 4:195-205.
27. Kennedy JC, Pottier RH. Using d-aminolevulinic acid in cancer therapy. ACS Symposium Series 1994; 559:291-302.
28. Dailey HA, Smith A. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem J 1984; 223: 441-445.
29. Schoenfeld N, Epstein O, Lahav M, Mamet R, Shaklai M, Atsmon A. The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders. Cancer Lett 1988; 43:43-48.
30. El-Sharabasy MMH, El-Waseef AM, Hafez MM, Salim SA. Porphyrin metabolism in some malignant diseases. Br J Cancer 1992; 65:409-412.
31. Wilson JHP, van Hillegersberg R, van den Berg JWO, Kort WJ, Terpsta OT. Photodynamic therapy for gastrointestinal tumors. Scand J Gastroenterol 26 (Suppl) 1991; 188:20-25.
32. Wilson JHP, van Hillegersberg R, van den Berg JWO, Kort WJ, Terpsta OT. Photodynamic therapy for gastrointestinal tumors. Scand J Gastroenterol 26 (Suppl) 1991; 188:20-25.
33. Rebeiz N, Rebeiz CC, Arkins S, Kelley KW, Rebeiz CA. Photodestruction of tumor cells by induction of endogenous accumulation of protoporphyrin IX: enhancement by 1,10-phenathroline. Photochem Photobiol 1992; 55:431-435.
34. Peng Q, Moan J, Warloe T, Nesland JM, Rimington C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer 1992; 52:433-443.
35. van Hillegersberg R, van den Berg JWO, Kort WJ, Terpstra OT, Wilson JH. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology 1992; 103:647-651.
36. Hinnen P, de Rooij FMW, van Velthuysen MLF, et al. Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer 1998; 78:679-682.
37. Cincotta L, Foley JW, MacEachern T, Lampros E, Cincotta AH. Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas. Cancer Res 1994; 54:1249-1258.
38. Truscott TG, McLean AJ, Phillips AMR, Foulds WS. Detection of haematoporphyrin derivative and haematoporphyrin excited states in cell environments. Cancer Lett 1980; 41:31-45.
39. Sliney DH, Trokel SL. Medical lasers and their safe use. New York: Springer-Verlag; 1992.
40. Svaasand LO, Ellingsen R. Optical penetration in human intracranial tumors. Photochem Photobiol 1985; 41:73-76.
41. Barr H, Bown SG, Krasner N, Boulos PB. Photodynamic therapy for colorectal disease. Int J Colored Dis 1989; 4:15-19.
42. Loh CS, Bedwell J, MacRobert AJ, et al. Photodynamic therapy of normal rat stomach: a comparative study between di-sulfonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br J Cancer 1992; 66:452-462.
43. Barr H, Tralau CJ, MacRobert AJ, et al. Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. Br J Cancer 1987; 56:111-118.
44. Bown SG, Tralau CJ, Smith PD, Akdemir D, Wieman TJ. Photodynamic therapy with porphyrin and phthalocyanine sensitisation in normal rat liver. Br J Cancer 1986; 54:43-52.
45. Henderson BW, Finger VH. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 1987; 47:3110-3114.
46. Moan J. Effect of bleaching of porphyrin sensitizers during photodynamic therapy. Cancer Lett 1986; 33:45-53.
47. Potter WR, Mang TS, Dougherty TJ. The theory of photodynamic therapy dosimetry: consequences of photodestruction of sensitizer. Photochem Photobiol 1987; 46:97-101.
48. Nseyo UO, Whalen RK, Duncan MR, Berman B, Lundahl SL. Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. Urology 1990; 36:167-171.
49. Regula J, MacRobert AJ, Gorchein A, et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal and colorectal tumours using 5-aminolaevulinic acid induced protoporphyrin IX - a pilot study. Gut 1995; 36:67-75.
50. Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer 1993; 68:41-51.
51. Van der Veen N, Van Leengoed HLLM, Star WM. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br J Cancer 1994; 70:867-872.
52. Imamura S, Kusunoki Y, Takifuji N, et al. Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer. Cancer 1994; 73:1608-1614.
53. Gossner L, Hahn EG, Ell C. Oral administration of 5-aminolaevulinic acid for photodynamic therapy in patients with gastrointestinal carcinomas: preliminary results [abst]. Gastroenterology 1994; 106: 387.
54. Bonnet R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev 1995; 24:19-33.
55. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992; 55:145-157.
56. Moan J, Berg K. Photochemotherapy of cancer: experimental research. Photochem Photobiol 1992; 55:931-948.
57. Star WM, Marijnissen HPA, van den Berg-Blok AE, Versteeg JA, Franken KA, Reinhold HS. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res 1986; 46:2532-2540.
58. Henderson BW, Fingar VH. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem Photobiol 1989; 49:299-304.
59. van Geel IPJ, Oppelaar H, Oussoren YG, Stewart FA. Changes in perfusion of mouse tumours after photodynamic therapy. Int J Cancer 1994; 56:224-228.
60. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implication for radiotherapy. Br J Cancer 1955; 9:539-549.
61. Mattiello J, Evelhoch JL, Brown E, Schaap AP, Hetzel FW. Effect of photodynamic therapy on RIF-1 tumor metabolism and blood flow examined by 31P and 2H NMR spectroscopy. NMR Biomed 1990; 3:64-70.
62. West CML, West DC, Kumar S, Moore JV. A comparison of the sensitivity to photodynamic treatment of endothelial and tumour cells in different proliferative states. Int J Radiat Biol 1990; 58:145-156.
63. Leunig, M, Goetz AE, Gamarra F, Zetterer G, Messmer K, Jain RK. Photodynamic therapy-induced alterations in interstitial fluid pressure, volume and water content of an amelanotic melanoma in the hamster. Br J Cancer 1994; 69:101-103.
64. Roberts DJH, Cairnduff F, Driver I, et al. Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolaevulinic acid. Int J Oncol 1994; 5:763-768.
65. Bremner JCM, Bradley JK, Stratford IJ, Adams GE. Magnetic resonance spectroscopic studies on "real-time" changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy. Br J Cancer 1994; 69:1083-1087.
66. Agarwal ML, Clay ME, Harvey EJ, Evans HH, Antunez AR, Oleinick NL. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res 1991; 51:5993-5996.
67. He XY, Sikes R, Thomsen S, Chung LW, Jacques SL. Photodynamic therapy with Photofrin II induces programmed cell death in carcinoma cell lines. Photochem Photobiol 1994; 59:468-473.
68. Zaidi SIA, Oleinick NL, Zaim MT, Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochem Photobiol 1993; 58:771-776.
69. Webber J, Luo Y, Crilly R, Fromm D, Kessel D. An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. J Photochem Photobiol Biol 1996; 35:209-211.
70. Fisher TC, Miller AE, Gregory CD, et al. bcl-2 Modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 1993; 53:3321-3326.
71. Hickman JA, Potten CS, Merritt AJ, Fisher TC. Apoptosis and cancer chemotherapy. Phil Trans R Soc Lond B 1994; 345:319-325.
72. Dive C, Hickman JA. Drug-target interactions: only the first step in the commitment to a programmed cell death? Br J Cancer 1991; 64:192-196.
73. Raff MC. Social controls on cell survival and death. Nature 1992; 356:397-400.
74. Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992; 102:1319-1322.
75. Schoenfeld N, Mamet R, Nordenberg Y, Shafran M, Babushkin T, Malik Z. Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation. Int J Cancer 1994; 56:106-112.
76. Abulafi AM, Williams NS. Photodynamic therapy for cancer: still awaiting rigorous evaluation. Br Med J 1992; 304:589-900.
77. van Gemert JC, Berenbaum MC, Gijsbers GHM. Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrine derivative. Br J Cancer 1985; 52:43-49.
78. Barr H, Krasner N, Boulos PB, Chatlani P, Bown SG. Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 1990; 77:93-96.
79. Popovic EA, Kaye AH, Hill JS. Photodynamic therapy of brain tumors. J Clin Laser Med Surg 1996; 14:251-261.
80. Strechkyte G, Berg K, Moan J. Photomodification of ALA-induced proporphyrin IX in cells in vitro. SPIE 1994; 2325:58-65.
81. Evrard S, Aprahamian M, Marescaux J. Intra-abdominal photodynamic theraphy: from theory to feasibility. Br J Surg 1993; 80:298-303.
82. Roberts WG, Smith KM, McCullough JL, Berns MW. Skin photosensitivity and photodestruction of several photodynamic sensitizers. Photochem Photobiol 1989; 49:431-438.
83. Bellnier DA, Dougherty TJ. A preliminary pharmacokinetic study of intravenous Photofrin in patients. J Clin Laser Med Surg 1996; 14:311-314.
84. Sibille A, Lambert R, Souquet J-C, et al. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995; 108:337-344.
85. Farber NE, McNeely J, Rosner D. Skin burn associated with pulse oximetry during perioperative photodynamic therapy. Anesthesiology 1996; 84:983-985.
86. Herman, MA, Webber J, Fromm D, Kessel D. Hemodynamic effects of 5-aminolevulinic acid in humans. J Photochem Photobiol Biol 1998; 43:61-65.
87. Herrera-Ornelas L, Petrelli NJ, Mittelman A, Dougherty TJ, Boyle DG. Photodynamic therapy in patients with colorectal cancer. Cancer 1986; 57:677-84.
88. Nambisan RN, Karakousis CP, Holyoke ED, Dougherty TJ. Intraoperative photodynamic therapy for retroperitoneal sarcomas. Cancer 1988; 61:1248.
89. Goff BA, Bachor R, Kollias N, Hasan T. Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs. J Photochem Photobiol Biol 1992; 15:239-251.
90. Schuitmaker JJ, Baas P, van Leengoed HLLM, van der Meulen FW, Star WM, van Zandwijk N. Photodynamic therapy: a promising new modality for the treatment of cancer. J Photochem Photobiol Biol 1996; 34:3-12.
91. van Hillegersberg R, Kort WJ, Wilson JHP. Current status of photodynamic therapy in oncology. Drugs 1994; 48:510-527.
92. Fromm D, Kessel D, Webber J. Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer. Arch Surg 1996; 131:667-669.
93. Kato H, Kawaguchi M, Konaka C, et al. Evaluation of photodynamic in gastric cancer. Lasers in Med Sci 1986; 1:67-74.
94. Parker EF, Marks RD, Kratz JM, Chaikhouni A, Warren ET, Bartles DM. Chemoradiation therapy and resection for carcinoma of the esophagus: short-term results. Ann Thorac Surg 1985; 40:121-125.
95. Moghissi K, Dixon K, Hudson E, Stringer M. Photodynamic therapy of oesophageal cancer. Lasers in Med Sci 1995; 10:67-71.
96. Grant WE, Hopper C, MacRobert AJ, Speight PM, Bown SG. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet 1993; 342:147-48.
97. Earlam R, Cunah-Melo JR. Oesophageal squamous cell carcinoma: a critical review of surgery. Br J Surg 1980; 67:381-390.
98. McCaughan JS, Williams TE, Bethel BH. Palliation of esophageal malignancy with photodynamic therapy. Ann Thorac Surg 1985; 40(2):113-120.
99. McCaughan JS, Nims TA, Guy JT, Hicks WJ, Williams TE, Laufman LR. Photodynamic therapy for esophageal tumors. Arch Surg 1989; 124:74-80.
100. Hayata Y, Kato H, Okitsu H, Kawaguchi M, Konaka C. Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastrointestinal tract. Semin Surg Oncol 1985; 1:1-11.
101. Thomas RJ, Abbott M, Bhathal PS, St. John DJB, Morstyn G. High-dose photoirradiation of esophageal cancer. Ann Surg 1987; 206(2): 193-199.
102. Patrice T, Foultier MT, Yactayo S, et al. Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients. Digest Dis Sci 1990; 35(5):545-552.
103. Spinelli P, Dal Fante M, Mancini A. Current role of laser and photodynamic therapy in gastrointestinal tumors and analysis of a 10-year experience. Semin Surg Oncol 1992; 8:204-213.
104. Spinelli P, Mancini A, Dal Fante M. Endoscopic treatment of gastrointestinal tumors: indications and results of laser photocoagulation and photodynamic therapy. Semin Surg Oncol 1995; 11:307-318.
105. Heier SK, Rothman KA, Heier LM, Rosenthal WS. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy. Gastroenterology 1995; 109:63-72.
106. Bown SG, Millson CE. Photodynamic therapy in gastroenterology. Gut 1997; 41:5-7.
107. Lightdale CJ, Heier SK, Marcon ME, et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 1995; 42(6):507-512.
108. Wright TA. High-grade dysplasia in Barrett's oesophagus. Br J Surg 1997; 84:760-766.
109. Orringer MB. Tumors of the esophagus. In: Sabiston DC Jr (ed). Textbook of surgery. Philadelphia: WB Saunders; 1997:744-758.
110. Ferguson MK, Naunheim KS. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardio Surg 1997; 114:824-829.
111. Edwards MJ, Gable DR, Lentsch AB, Richardson JD. The rationale for esophagectomy as the optimum therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996; 223:585-591.
112. Overholt BF, Panjehpour M. Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer. Gastrointest Endosc 1995; 42:64-70.
113. Overholt B, Panjehpour M, Tefftellar E, Rose M. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. Gastrointest Endosc 1993; 39:73-76.
114. Gossner L, Sroka R, Hahn EG, Eli C. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. Gastrointest Endosc 1995; 41(1):55-58.
115. Laukka MA, Wang KK. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc 1995; 42:59-63.
116. Overholt BF, Panjehpour M. Photodynamic therapy in Barrett's esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer. Semin Surg Oncol 1995; 11:372-376.
117. Overholt BF, Panjehpour M. Photodynamic therapy in Barrett's esophagus. J Clin Laser Med Surg 1996; 14:245-249.
118. Collen MJ, Strong RM. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecrection. Dig Dis Sci 1992; 37:897-903.
119. Deviere J, Buset M, Dumonceau JM, Riskaert F, Cremer M. Regression of Barrett's epithelium with omeprazole [letter]. N Engl J Med 1989; 320:1497-1498.
120. Okuda S, Mimura S, Otani T, Ichii M, Tatsuta M. Experimental and clinical studies on HPD-photoradiation therapy for upper gastrointestinal cancer. In: Andreoni A, Cubeddu R (eds). Porphyrins in tumor phototherapy. New York: Plenum; 1984:413-421.
121. Tajiri H, Daikuzono N, Joffe SN, Oguro Y. Photoradiation therapy in early gastrointestinal cancer. Gastrointest Endosc 1987; 33(2): 88-90.
122. Jin M, Yang B, Zhang W, Wang Y. Photodynamic therapy for upper gastrointestinal tumours over the past 10 years. Semin Surg Oncol 1994; 10:111-113.
123. Mang TS, Wieman TJ. Photodynamic therapy in the treatment of pancreatic carcinoma: dihematoporphyrin ether uptake and photobleaching kinetics. Photochem Photobiol 1987; 46:853-858.
124. Schroder T, Chen IW, Sperling M, Bell RH, Brackett K, Joffe SN. Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma. J Surg Oncol 1988; 38:4-9.
125. Chatlani PT, Nuutinen PJO, Toda N, et al. Selective necrosis in hamster pancreatic tumors using photodynamic therapy with phthalocyanine photosensitization. Br J Surg 1992; 79:786-790.
126. Regula J, Ravi B, Bedwell J, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolevulinic acid for experimental pancreatic cancer - prolonged animal survival. Br J Cancer 1994; 70:248-254.
127. Evrard S, Keller P, Hajri A, et al. Experimental pancreatic cancer in the rat treated by photodynamic therapy. Br J Surg 1994; 81:1185-1189.
128. Mlkvy P, Messmann H, Pauer M, et al. Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer 1996; 73:1473-1479.
129. Mlkvy P, Messmann H, MacRobert AJ, et al. Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxy-phenylchlorin (mTHPC). Br J Cancer 1997; 76:713-718.
130. McCaughan JS, Mertens BF, Cho CH, Barabash RD, Payton HW. PDT to treat tumors of the extrahepatic biliary ducts. Arch Surg 1991; 126:111-113.
131. Ortner ME, Liebetruth J, Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998; 114: 536-542.
132. Kashtan H, Papa MZ, Wilson B, Deutch AA, Stern HS. Use of photodynamic therapy in the palliation of massive advanced rectal cancer: phase I/II study. Dis Colon Rectum 1991; 34:600-605.
133. Loh CS, Bliss P, Bown SG, Krasner N. Photodynamic therapy for villous adenomas of the colon and rectum. Endoscopy 1994; 26:243-246.
134. Mlkvy P, Messmann H, Debinski H, et al. Photodynamic therapy for polyps in familial adenomatous polyposis - a pilot study. Eur J Cancer 1995; 31A:1160-1165.
135. Brunetaud JM, Maunoury V, Cochelard D. Lasers in rectosigmoid tumors. Semin Surg Oncol 1995; 11:319-327.